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Abstract
Background: Abnormal immune responses are believed to be highly relevant in the pathogenesis of chronic 
obstructive pulmonary disease (COPD). Dendritic cells provide a critical checkpoint for immunity by their capacity to 
both induce and suppress immunity. Although evident that cigarette smoke, the primary cause of COPD, significantly 
influences dendritic cell functions, little is known about the roles of dendritic cells in the pathogenesis of COPD.
Methods: The extent of dendritic cell infiltration in COPD tissue specimens was determined using 
immunohistochemical localization of CD83+ cells (marker of matured myeloid dendritic cells), and CD1a+ cells 
(Langerhans cells). The extent of tissue infiltration with Langerhans cells was also determined by the relative expression 
of the CD207 gene in COPD versus control tissues. To determine mechanisms by which dendritic cells accumulate in 
COPD, complimentary studies were conducted using monocyte-derived human dendritic cells exposed to cigarette 
smoke extract (CSE), and dendritic cells extracted from mice chronically exposed to cigarette smoke.
Results: In human COPD lung tissue, we detected a significant increase in the total number of CD83+ cells, and 
significantly higher amounts of CD207 mRNA when compared with control tissue. Human monocyte-derived dendritic 
cells exposed to CSE (0.1-2%) exhibited enhanced survival in vitro when compared with control dendritic cells. Murine 
dendritic cells extracted from mice exposed to cigarette smoke for 4 weeks, also demonstrated enhanced survival 
compared to dendritic cells extracted from control mice. Acute exposure of human dendritic cells to CSE induced the 
cellular pro-survival proteins heme-oxygenase-1 (HO-1), and B cell lymphoma leukemia-x(L) (Bcl-xL), predominantly 
through oxidative stress. Although activated human dendritic cells conditioned with CSE expressed diminished 
migratory CCR7 expression, their migration towards the CCR7 ligand CCL21 was not impaired.
Conclusions: These data indicate that COPD is associated with increased numbers of cells bearing markers associated 
with Langerhans cells and mature dendritic cells, and that cigarette smoke promotes survival signals and augments 
survival of dendritic cells. Although CSE suppressed dendritic cell CCR7 expression, migration towards a CCR7 ligand 
was not diminished, suggesting that reduced CCR7-dependent migration is unlikely to be an important mechanism for 
dendritic cell retention in the lungs of smokers with COPD.
Introduction
Chronic obstructive pulmonary disease (COPD) is a
slowly progressive destructive lung disease induced pri-
marily by cigarette smoking in developed countries [1].
Although COPD is associated with significant abnormali-
ties in local immunity, the precise roles of inflammation,
and the distinct roles of innate and acquired immune cells
in the pathogenesis of COPD remain incompletely char-
acterized [2]. Among the immune cell types infiltrating
the COPD airways, the extent of CD8 T cell, and small
airway dendritic cell infiltration correlate with COPD
severity as determined by lung function testing, suggest-
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ing that these immune cells play important roles in the
pathogenesis [3].
Dendritic cells are rare but critical immune cells that
are distributed in sub-epithelial, interstitial and pleural
compartments, where they usually exist as immature
antigen presenting cells [4]. At least three major pheno-
typic and functional subsets have been described; classic
or conventional myeloid dendritic cells, epithelial-associ-
ated CD1a positive dendritic cells (analogous to epithelial
associated Langerhans cells in the skin), and plasmacy-
toid dendritic cells [4,5]. The effect of smoking on den-
dritic cell profusion and activation in COPD is somewhat
controversial with recent studies showing conflicting
findings [3,6,7]. Demedts and colleagues reported that
the accumulation of CD207-positive dendritic cells
(Langerhans cells) in the epithelium and adventitia of
small airways in COPD was greater than that occurring in
never-smokers or smokers without COPD [3]. Demedts
et al also reported that the number of Langerhans cells in
the small airways of COPD patients increase in propor-
tion with disease severity, suggesting that these abnor-
mally accumulated Langerhans cells may directly
participate in the pathogenesis of COPD [3]. In contrast,
another study reported no difference in the numbers of
Langerhans cells in the airway biopsies of smokers with
CO PD whe n c o m pa r ed t o e x -s m ok e rs  or  non-s m ok e r s
without COPD [6].
The current study was designed to determine whether
COPD is associated with increased numbers of Langer-
hans-type dendritic cells (defined by surface expression
of CD1a, or the presence of transcripts for the Langer-
hans cell restricted gene CD207), or matured dendritic
cells (defined by surface CD83 expression), utilizing
human COPD lung tissue procured through the Lung
Tissue Research Consortium (LTRC). In addition, com-
plimentary studies were conducted using relevant in vitro
human and in vivo murine models to determine mecha-
nisms by which cigarette smoke constituents promote
dendritic cell persistence in the lung. Specifically, we
sought to determine whether cigarette smoke promotes
dendritic cell retention in the lung by promoting den-
dritic cell survival. In addition, we sought to determine
the effect of cigarette smoke constituents on key migra-
tory chemokine expression and migratory capacity of
dendritic cells.
Methods
Immunohistochemical detection of dendritic cells in COPD 
tissue
Slides of formalin-fixed, paraffin-embedded specimens
were obtained from twenty-four patients - 8 controls
(these control subjects would have been classified as
GOLD stage 0, or at risk subjects based on the 2001
GOLD guidelines [8], but would now be classified as not
having spirometric criteria of COPD based on a post-
bronchodilator FEV1/FVC ratio > 70% and % predicted
FEV1 > 80; 1 subject had an FEV1 of 78% predicted but an
FEV1/FVC ratio > 70% [9]), 8 with moderate (post-bron-
chodilator FEV1/FVC ratio < 70%; FEV1  50-80% pre-
dicted), and 8 with severe COPD (post-bronchodilator
FEV1/FVC ratio < 70%, FEV1 < 50%) based on spirometry.
All tissue samples were obtained from the National Insti-
tutes of Health funded Lung Tissue Research Consortium
(LTRC: http://www.ltrcpublic.com - a detailed account of
the LTRC protocol used is available to the public at http:/
/www.ltrcpublic.com/PRO_NOV_2009.pdf). Asthma and
other causes of obstructive lung disease were excluded in
all subjects based on history, physical examination, and
spirometric data. Tissue sections were de-paraffinized in
3 changes of xylene (5 minutes each), hydrated in 2
changes of 100% ethanol (10 minutes each), and subse-
quently hydrated in 2 changes of 95% ethanol (10 minutes
each). Antigen unmasking was performed in a pressure
cooker and with 10 mM sodium citrate buffer, pH 6.0.
Endogenous peroxidase activity was quenched by placing
slides in a 1% hydrogen peroxide solution in methanol for
30 minutes. Tissue slides were then washed (1× Dako
Wash Buffer) and immunostaining performed using a
commercially available VectaStain Elite ABC (Vector
Labs) kit according to the manufacturer's instructions.
Tissues were stained using CD1a (Dako; marker for
Langerhans cells) and CD83 (Dako; marker for mature
dendritic cells). Images of the stained tissue were digitally
captured at a 10× magnification using a NanoZoomer
system (Bacus laboratories, Olympus America). The per-
cent area of lung tissue positively stained for CD1a and
CD83 were quantitatively determined using IHCscore
software (Bacus lab, Olympus America), as recently
described [10]. Image capture and quantitative determi-
nation of tissue staining for CD1a and CD83 were per-
formed by one the investigators (JL) in a blinded manner
(control vs COPD). The area of tissue positively stained
was estimated relative to the area of total lung tissue pres-
ent on the slide to determine the extent of Langerhans
cell and mature dendritic cell infiltration for each sample.
Relevant demographic and physiologic lung function
variables for the study population were obtained from
LTRC. Correlations were performed between quantita-
tive surface marker expression (CD1a and CD83) and
cumulative tobacco exposure (pack years of cigarette
smoked), as well as physiologic lung function measure-
ments.
Determination of CD207 and Osteopontin gene expression 
levels in COPD and control tissues
Quantitative real-time RT-PCR was performed to deter-
mine the relative expression of Langerhans cell restricted
CD207 (langerin) gene transcripts in COPD and controlVassallo et al. Respiratory Research 2010, 11:45
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tissues. For qPCR analysis, the CFX96 Real-Time PCR
detection System was utilized (Bio-Rad). RNA was
extracted from whole lung frozen tissue using a Qiagen
RNA isolation kit. RNA was extracted only from frozen
tissue specimens, and all extractions were performed in
batch format in the institutional Advanced Genomics
Technology Center. Samples with an RNA Integrity
Number (RIN: determined by Agilent Bioanalyzer soft-
ware) < 7.5 were excluded from the analysis. To make
cDNA for qPCR analysis, SuperScript® III Reverse Tran-
scriptase was employed (Invitrogen). To quantify the final
cDNA PCR products, SYBR® Green PCR Master Mix was
used. Conditions for the PCR reactions were as follows:
50°C for 2 min, 95°C for 2 min, followed by 40 cycles of
95°C for 15 sec, 60°C for 30 sec, and 72°C for 30 sec. Dur-
ing the 72°C temperature, analysis of the SYBR fluoro-
phore for quantification was conducted. Relative
expression levels of CD207 mRNA were calculated by
normalizing to the level of GAPDH mRNA by using com-
parative threshold cycle (ct) method, in which fold differ-
ence = 2-(Δct of target gene-Δct of reference). Primers for
amplification of CD207 mRNA were 5'-GTGGACAAA-
CAGAACATCTCCCTC-3' and 5'-GACCTTTCAG-
CAACTGGACATTG-3'. GAPDH transcript was
amplified with primers 5'-CGGTATTTGGTCGTATTG-
GGC-3' and 5'-TGGAAGATGGTGATGGGATTTC-3'.
An identical approach was used to determine the relative
expression levels of osteopontin mRNA using the follow-
ing primers: 5'-GCAGTGATTTGCTTTTGCCTCC-3'
and 5'-CTTTCGTTGGACTTACTTGGAAGG-3'.
Generation of cigarette smoke extract (CSE)
For  in vitro studies, aqueous CSE was prepared from
Kentucky research cigarettes 3RF4 as recently described
[11]. The nicotine levels in the CSE preparations were
measured in the Mayo institutional clinical laboratory
using liquid chromatography-tandem mass spectrome-
try: the nicotine content measured in 1% CSE was 174 ng/
ml. Cellular experiments were conducted with CSE con-
centrations <3% because of viability studies that demon-
strated cellular toxicity as determined by the XTT assay
and AnnexinV/propridium iodide staining with CSE
preparations >3%.
Human monocyte-derived dendritic cells
Human monocytes were isolated from buffy coats
obtained from healthy non-smoking adult blood donors,
and monocyte-derived dendritic cells were generated
using a 6 day differentiation protocol with recombinant
human IL-4 and GM-CSF as previously described [11,12].
Maturation was induced by overnight culture with 100
ng/ml lipopolysaccharide [LPS from E. coli; Sigma] unless
otherwise specified.
Determination of cellular protein levels by immunoblotting
Semi-quantitative determination of cellular protein levels
were obtained by immunoblotting as recently described
[12]. Human monocyte-derived dendritic cells were
plated at a concentration of 1 × 106/ml in complete media
[RPMI, 10% fetal bovine serum] and GM-CSF/IL-4 as
previously described [12]. Cigarette smoke extract and
LPS were added to the cells at the time points indicated.
Protein lysates were prepared using RIPA buffer [150 mM
NaCl, 1.0% Igepal CA-630, 0.5% sodium deoxycholate,
0.1% SDS, 50 mM Tris] as recently described [12]. Anti-
bodies used in immunoblotting included Bcl-xL (Cell Sig-
naling # 2762), HO-1 (Stressgen # SPA-896), and CCR7
(eBioscience # 14-9977-82).
Determination of dendritic cell migration
Human monocyte-derived dendritic cells were treated for
18 hours with 100 ng/ml of LPS and 50 ng/ml of IFN-γ,
with or without 2% CSE, or 2% CSE and 1 mM NAC.
After this period of activation, dendritic cells were
washed in RPMI, and equal numbers (0.5 × 106) were
placed in 0.5 ml of RPMI without serum and assayed for
migration towards CCL21 placed in the lower chamber of
a transwell plate. The lower chambers of Transwell plates
(5.0-μm pore size; Corning, Acton, MA) were filled with
0.5 ml of complete media (RPMI with 10% fetal calf
serum) supplemented with 10 ng/ml CCL21. Human
dendritic cells placed in the upper chambers of the Tran-
swell plates were allowed to migrate to the lower chamber
for 4 hours at 37°C in 5% CO2. The total numbers of
migrated dendritic cells from the lower chambers were
determined by flow cytometry (60-second counts).
In vivo exposure of mice to cigarette smoke
All murine experiments described were approved by the
institutional animal use and care committee. To further
expand on our in vitro studies, we conducted in vivo stud-
ies to determine the effect of chronic cigarette smoking
on lung and systemic dendritic cell survival. Mice were
chronically exposed to cigarette smoke generated from a
Teague TE-2 system, as recently described [12]. This
smoking chamber is a manually-controlled cigarette
smoking machine that produces a combination of side-
stream and mainstream cigarette smoke in a chamber,
which is then transported to a collecting and mixing
chamber where varying amounts of air is mixed with the
smoke mixture. In this model, mice were exposed to reg-
ulated concentrations of cigarette smoke generated from
2 cigarettes every 10 minutes for a total of 3 hours/day, 5
days/week for a total of 4-6 weeks. Following 4-6 weeks in
the smoking chamber, mice were sacrificed, blood was
removed by right heart puncture and submitted for nico-
tine analyses, and dendritic cells from lung and splenic
tissues isolated as recently described [12].Vassallo et al. Respiratory Research 2010, 11:45
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Statistical Analysis
Statistical differences were considered to be significant if
P was <0.05. For the lung tissue analysis, data is expressed
as means and comparisons between means were per-
formed using the Mann Whitney U test. Correlations
between lung tissue characteristics and clinical parame-
ters were performed using the Spearman test. For the in
vitro  studies with dendritic cells, data is expressed as
means and standard error, while comparison between
multiple means was done with ANOVA. Statistical analy-
sis was performed using SigmaPlot5. Densitometry was
performed using Image J software http://rsbweb.nih.gov/
ij/.
Results
Dendritic cells accumulate in COPD lungs
Accumulation of matured myeloid dendritic cells
(defined as CD83+), or Langerhans-type dendritic cells
(defined as CD1a+) in lung biopsy specimens, was evalu-
ated in 24 subjects from the LTRC database. Subject char-
acteristics are shown in Table 1. As expected, the %
predicted FEV1 and FEV1/FVC ratio were significantly
lower in patients with COPD when compared with con-
trol subjects. Rather than count specific numbers of cells,
quantitative measures of expression for the dendritic cell
receptors, CD83 and CD1a, were estimated from elec-
tronically scanned entire control and COPD tissue slides,
and the relative intensity of expression for either marker
were determined using image capture analysis. A statisti-
cally significant increase in CD83+ staining cells - a cell
surface receptor expressed by matured dendritic cells -
was detected in COPD tissues compared to control tis-
sues (Figure 1A, Mann Whitney U p = 0.049). The extent
of CD83+ staining correlated with cumulative tobacco
consumption defined by pack years of cigarettes smoked
(R 0.398, p = 0.026), but did not correlate with % pre-
dicted FEV1 (R -0.194, p = 0.182) or % predicted DLCO (R
-0.084, p = 0.348). The extent of CD83 staining on tissue
slides also correlated with intensity of CD1a expression
(R 0.566, p = 0.002). Quantitative total tissue expression
of CD1a did not show a statistically significant difference
between control and COPD tissue (Figure 1B, Mann
Whitney U p = 0.301). The extent of CD1a staining on tis-
sue slides did not correlate with cumulative pack years
smoked (R 0.305, p = 0.073) or % predicted FEV1 (R -
0.241, p = 0.128), but inversely correlated with the % pre-
dicted DLCO (R -0.350, p = 0.047).
As the extent of CD1a positive staining in COPD tissue
appeared to show a higher trend in comparison with con-
trol tissue, we determined the relative amounts of CD207
mRNA as an alternative approach to determine whether
smokers with COPD have increased numbers of Langer-
hans cells infiltrating lung tissue. To determine this, RNA
was extracted from 12 frozen lung biopsy samples avail-
able from the tissue samples used in the immunohis-
tochemical approach described above (the remaining
samples could not be used as the extracted RNA was not
of adequate quality), and an additional 22 frozen lung
samples obtained through the LTRC. All samples used in
this analysis had RIN > 7.5. The 34 samples analyzed
included 7 controls without COPD (mean % predicted
FEV1 91.3, range 84-103) and 27 COPD subjects (mean %
predicted FEV1  38.3, range 22-75). All patients were
either current or former smokers. A statistically signifi-
cant increase in CD207 mRNA was found in lung tissue
with COPD compared to lung tissue without COPD; Fig-
ure 1C, mean/SE CD207 expression 1.335 ± 0.627 vs
0.389 ± 0.128 respectively; p = 0.048.
Recent studies have shown that cigarette smoke
induces osteopontin production by lung epithelial cells
and macrophages [13,14]. Osteopontin is involved in the
regulation of Th-1 immunity and autoimmunity, is
chemotactic and anti-apoptotic to dendritic cells, and
when over-expressed in murine lungs, induces dendritic
cell recruitment [15,16]. Analysis of osteopontin mRNA
levels in the 7 control and 27 COPD tissues used to deter-
mine CD207 mRNA levels, did not show a significant dif-
ference between controls and COPD (0.188 ± 0.14 vs
0.297 ± 0.15 respectively, p = 0.17). Although osteopontin
mRNA levels were not significantly different between the
control and COPD groups, osteopontin mRNA levels in
the 27 tissue specimens with COPD correlated with
CD207 mRNA (R = 0.6529, p = 0.001). Taken together
these data indicate that COPD lung tissue is infiltrated by
greater numbers of both cells expressing the Langerhans
cell gene CD207, and matured CD83+ dendritic cells. The
correlation between osteopontin and CD207 mRNA lev-
els suggests a potential link between osteopontin regula-
tion and Langerhans cell infiltration in COPD.
Cigarette smoke extract and cigarette smoking promote 
dendritic cell survival
We speculated that enhanced dendritic cell survival may
be a potential mechanism by which the observed increase
in dendritic cell numbers occurs in COPD. To determine
whether cigarette smoke promotes dendritic cell survival,
immature human monocyte-derived dendritic cells were
generated and subsequently incubated with increasing
concentrations of freshly generated CSE (0.01 to 1%).
After 24 hours of incubation in a standard tissue culture
chamber, cellular viability was determined using the XTT
assay. A statistically significant increase in cellular viabil-
ity was observed when dendritic cells were incubated
with CSE concentrations >0.1% (Figure 2A, one-way
ANOVA p = 0.001; Dunnett's post-test for 0.1% CSE vs 0
and 1% CSE vs O = <0.05 and <0.001 respectively). ToVassallo et al. Respiratory Research 2010, 11:45
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Figure 1 COPD tissue contains increased numbers of CD83+ cells and CD207 (Langerin) mRNA levels compared to control tissue. A) Quan-
titative total tissue expression of CD1a+ cells identified in whole tissue slides from 8 controls and 16 COPD subjects. The values on the vertical axis 
refer to the area of positive staining relative to the entire scanned tissue biopsy. Graph shows mean and SEM of all data points. NS = not significant. 
B) Quantitative total tissue expression of CD83+ cells in 8 controls and 16 COPD subjects. The values on the vertical axis refer to the area of positive 
staining relative to the entire scanned tissue biopsy. Graph shows mean and SEM of all data points. C) Increased CD207 mRNA expression in total lung 
tissue from patients with COPD (n = 27) compared with controls without COPD (n = 7). Relative CD207 mRNA expression is shown as the ratio of the 
number of transcripts for CD207 to the number of transcripts for the housekeeping gene GAPDH. Graph shows mean and SEM of all data points. D) 
Representative images demonstrating the dendritic cells with dark brown membranous positivity on CD1a (left panel) and CD83 (right panel) stain-
ings. Right panel; 58-year old ex-smoker with FEV1 63% predicted. Left panel; 78-year old ex-smoker with FEV1 60% predicted.
Table 1: Demographic and pulmonary function characteristics of 16 COPD patients and 8 control subjects from whose 
lung biopsies were used for immunohistochemical detection of CD1a+ Langerhans cells and CD83+ mature dendritic cells.
Controls COPD P value
Gender M:F 2:6 9:7
Age - median (range) 63.5 (56-78) 65.5 (49-78) 0.779
Smoking history (pack years)
Median (range) 50.0 (2-110) 51.5 (5-180) 0.625
FEV1 (% predicted)
Median (range) 88.0 (78-107) 43.5 (27-75) <0.001
FEV1/FVC - Median 101.5 59.7 <0.001
DLCO (% predicted)
Median (range) 62.0 (34-122) 54.0 (27-99) 0.416Vassallo et al. Respiratory Research 2010, 11:45
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further characterize whether cigarette smoke promotes
dendritic cell survival, we conducted complimentary
studies on lung and splenic dendritic cells (defined as
CD11c+ cells) extracted from mice exposed to cigarette
smoke for ≥4 weeks in a Teague smoking chamber as pre-
viously described [11,12]. Lung and spleen dendritic cells
were purified by magnetic sorting [12], and adjusted to a
concentration of 1 × 106/ml in media containing 5 ng/ml
o f  m u r i n e  G M - C S F .  V i a b i l i t y  o f  i m m a t u r e  a n d  L P S -
matured lung and splenic dendritic cells from cigarette
smoke exposed mice and control mice was performed
using XTT assay following 24 hours of incubation in a
culture chamber. Consistent with the observed effect on
human dendritic cells, a statistically significant increase
in viability was observed in both murine lung and sys-
temic (spleen) dendritic cells from cigarette smoke
exposed mice, in comparison with control mice (Figure
2B; 2-way ANOVA p = 0.007 for smoking effect: Figure
2C; 2-way ANOVA p < 0.001 for smoking effect). Thus,
chronic exposure to cigarette smoke in vivo enhances ex
vivo survival of both immature and LPS-matured lung
and systemic dendritic cells. Cigarette smoke and CSE
contain thousands of chemicals: to determine whether
the nicotine component of cigarette smoke or CSE
enhances dendritic cell survival in vitro, human dendritic
cells were incubated with nicotine for up to 48 hours and
viability measured with the XTT assay. Incubation of
dendritic cells with nicotine concentrations that include
those described in the circulation of active smokers
[17,18], and those measured in CSE, failed to augment
dendritic cell survival in vitro (Figure D and E, p < 0.05 by
ANOVA).
Cigarette smoke extract induces dendritic cell survival 
proteins
The observation that both CSE and cigarette smoke expo-
sure enhance dendritic cell survival, led us to speculate
Figure 2 Cigarette smoke extract and cigarette smoking promote dendritic cell survival. A) Human dendritic cells (1 × 106/ml in complete me-
dia) were incubated in the presence of absence of CSE (0.01 to 1%) for 24 hours prior to determination of cellular viability using the XTT assay. *p < 
0.05 and ***p < 0.001 compared to control (Dunnett's test). Data shown is representative of four independent experiments. B) Lung CD11c+ dendritic 
cells were extracted from mice exposed to cigarette smoke for ≥4 weeks in a smoking chamber and adjusted to a concentration of 1 × 106/ml in media 
containing 5 ng/ml of murine GM-CSF. Viability of immature and LPS-matured lung dendritic cells from 4 cigarette smoke exposed mice and 4 control 
mice was performed using XTT assay following 24 hours of incubation. iDC = immature DC. 2-way ANOVA p < 0.01. C) Spleen CD11c+ dendritic cells 
were also extracted from mice exposed to cigarette smoke for ≥4 weeks in a smoking chamber and adjusted to a concentration of 1 × 106/ml in media 
containing 5 ng/ml of murine GM-CSF. Viability of immature and LPS-matured spleen dendritic cells was also performed using XTT assay following 24 
hours of incubation. Data shown in B and C are representative of 2 independent experiments. D and E) Human dendritic cells (1 × 106/ml in complete 
media) were incubated with 0-1000 ng/ml nicotine for 24 or 48 hours prior to determination of viability with an XTT assay. Data shown in D and E are 
representative of 3 independent experiments. Data shown are means ± SEM. *p < 0.05, **p < 0.01.
A. B. C. 
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that cigarette smoke constituents activate pro-survival or
anti-apoptotic factors in dendritic cells. To test this,
human dendritic cells were incubated with CSE, and cel-
lular levels of known pro-survival factors were deter-
mined using immunoblotting. Following variable periods
of incubation with CSE, protein lysates were prepared,
and the cellular levels of 2 key cell survival proteins previ-
ously described to be activated in smokers macrophages
[19] - heme-oxygenase-1 (HO-1), and Bcl-xL - were
determined. Figure 3A shows the induction of both HO-1
and Bcl-xL protein levels in whole cell lysates of dendritic
cells incubated with CSE. The induction of HO-1, an
inducible cytoprotective cellular sensor of oxidative
stress, occurs early and peaks by 8 hours following acute
stimulation. In contrast, the induction of Bcl-xL, an anti-
apoptotic member of the bcl family of proteins that pro-
motes dendritic cell survival in vitro [20] and in vivo [21],
accumulates after 24-48 hours of incubation with CSE
(Figure 3A). To determine whether cigarette smoke
induced oxidative stress is responsible for induction of
dendritic cell HO-1, human dendritic cells (1 × 106/ml
media) were incubated with complete media in the pres-
ence or absence of freshly-prepared 2% CSE, and in the
presence or absence of either 2.5 mM NAC as an inhibi-
tor of oxidative stress, or 10 μg/ml dexamethasone. NAC
and dexamethasone where added 60 minutes prior to
stimulation with CSE. Following 6 hours of incubation
with CSE and relevant inhibitors of oxidative stress
(NAC) or inflammatory gene transcription (dexametha-
sone), whole cell lysates were prepared, and equal
amounts of protein from each sample (50 μg) were sepa-
rated on a 12% gel and immunoblotting performed for
Figure 3 Cigarette smoke extract induces dendritic cell survival proteins. A) Human dendritic cells (1 × 106/ml complete media) were incubated 
with 2% CSE and cellular lysates prepared following 4, 8, 22 and 45 hours. Equal amounts of protein from whole cell lysates were electrophoretically 
separated, transferred to nitrocellulose, and analyzed for HO-1 and Bcl-xL protein using relevant antibodies as described in methods. β-Actin protein 
levels were determined as an internal control to ensure equal protein loading. Representative of two independent experiments. B) Human dendritic 
cells (1 × 106/ml) were incubated with complete media in the presence of absence of freshly-prepared 2% CSE, and in the presence or absence of 
either 2.5 mM NAC as an inhibitor of oxidative stress, or 10 μg/ml dexamethasone (NAC and dexamethasone where added 60 minutes prior to stim-
ulation with CSE). Following 6 hours, whole cell lysates were prepared, and 50 μg of total protein were separated on a 12% gel and immunoblotting 
performed for HO-1. Representative of 3 independent experiments. C) Pooled data from 3 independent experiments performed as outlined in 3B is 
summarized in graph format. Actin protein levels were determined as an internal control and densitometry was performed [ratio of HO-1: Actin de-
termined] using Image J software. The negative control samples (prepared from unstimulated dendritic cells) was arbitrarily assigned a 100% value. 
D) Human dendritic cells (1 × 106/ml) were incubated with complete media in the presence of absence of freshly-prepared 2% CSE or 1000 ng/ml of 
nicotine. In other wells, 2.5 mM NAC was added as an inhibitor of oxidative stress. Following 48 hours, whole cell lysates were prepared, and 50 μg of 
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HO-1. As illustrated in Figures 3B and 3C, CSE-induced
upregulation of HO-1 was completely suppressed by
NAC, but unaffected by dexamethasone, implicating oxi-
dative stress as the most likely inducer of HO-1 protein in
cigarette smoke stimulated dendritic cells. In parallel
experiments, we determined whether induction of Bcl-xL
protein by CSE was primarily induced by oxidative con-
stituents. To determine this, whole cell protein lysates
were prepared from human dendritic cells incubated in
the presence or absence of 2.5 mM NAC and stimulated
with 2% CSE for 48 hours. As shown in Figure 3D,
whereas CSE induced Bcl-xL protein, nicotine had virtu-
ally no effect on endogenous Bcl-xL levels. Dendritic cells
pre-incubated with NAC failed to upregulate Bcl-xL pro-
tein levels, indicating oxidative stress as a predominant
mechanism by which CSE induces Bcl-xL protein in den-
dritic cells.
Oxidative cigarette smoke constituents suppress dendritic 
cell CCR7 expression but do not suppress dendritic cell 
migration
In addition to augmented survival, we speculated that
cigarette smoke may promote retention and accumula-
tion of dendritic cells in the lung by diminishing migra-
tion to secondary lymph nodes. We focused our analysis
on CCR7 expression, since deficiency of CCR7 results in
impaired or absent migration of dendritic cells in mice
[22-24], and CCR7 was previously reported to be sup-
pressed in lung dendritic cells of smokers with COPD
[25]. The expression of CCR7 by immature and LPS-
matured human monocyte-derived dendritic cells was
determined following overnight incubation of dendritic
cells cultured in the presence of either 2% CSE or 1000
ng/ml nicotine. To determine whether CSE-induced oxi-
dative stress mediates suppression of CCR7 following
LPS activation, a control group of dendritic cells were
pretreated with 1 mM NAC for 60 minutes prior to the
addition of 2% CSE and LPS. As expected, LPS robustly
induced the expression of surface CCR7 (Figure 4A). The
addition of 2% CSE to the culture media, but not 1000 ng/
ml nicotine, resulted in significant reduction of surface
CCR7 expression (Figure 4A). Pre-incubation of dendritic
cells with NAC prior to the addition of CSE resulted in
complete abrogation of the inhibitory effect of CSE on
LPS-mediated dendritic cell CCR7 expression, implying
that oxidative stress is responsible for suppression of
CCR7 (Figure 4A). Identical findings were observed when
the effect of CSE on whole cellular CCR7 levels was
determined using immunoblotting (Figure 4B). In parallel
to the flow cytometric findings, dendritic cells incubated
overnight with CSE and LPS had substantially lower cel-
lular levels of CCR7 compared to dendritic cells activated
with LPS alone (Figure 4B). In addition, pre-incubation of
dendritic cells with 1 mM NAC 60 minutes prior to the
addition of CSE and LPS resulted in restoration of LPS-
induced whole cellular CCR7 levels (Figure 4B), suggest-
ing that rather than inhibiting translocation of preformed
CCR7 to the surface of dendritic cells, CSE inhibits de
novo formation of cellular CCR7 following LPS activa-
tion. To directly determine whether CSE suppresses
migration of dendritic cells, immature and LPS-activated
human dendritic cells were incubated with or without
CSE for 18 hours. Half a million dendritic cells under dif-
ferent conditions were washed and resuspended in 0.5 ml
RPMI without serum and placed in cell culture inserts.
The inserts were subsequently placed in a 12-well tissue
culture plate containing 0.5 ml of RPMI with 10% fetal
calf serum and 10 ng/ml of CCL21, the respective ligand
for CCR7. After 4 hours of incubation in a tissue culture
chamber, the number of cells that migrated from the
insert to the lower chamber was quantified. As expected,
few immature dendritic cells migrated from the upper
chamber to the lower chamber, while dendritic cells
matured with LPS demonstrated a marked increase in
migratory capacity (1745 ± 6.3 vs 10665 ± 106.1 cells; p <
0.001 with 1-way ANOVA and Bonferroni's Multiple
Comparison Test). Surprisingly, dendritic cells activated
with LPS in the presence of CSE did not demonstrate a
reduction in migratory capacity (Figure 4C). In contrast,
migration of LPS-activated dendritic cells conditioned
with CSE towards the CCR7 ligand was augmented (Fig-
ure 4C; 10665 ± 106.1 vs 14385 ± 551.5 cells for LPS-acti-
vated dendritic cells and CSE-conditioned LPS-activated
dendritic cells respectively; p < 0.001 with 1-way ANOVA
and Bonferroni's Multiple Comparison Test). Although
CSE did not diminish migration of LPS-activated den-
dritic cells towards CCL21, a statistically significant
reduction in migration was observed in LPS-activated
dendritic cells conditioned with 1000 ng/ml nicotine (Fig-
ure 4C; 10665 ± 106.1 vs 8205 ± 275.8 cells for LPS-acti-
vated dendritic cells and nicotine conditioned LPS-
activated dendritic cells respectively; p < 0.01 with 1-way
ANOVA and Bonferroni's Multiple Comparison Test).
Discussion
Recent studies have demonstrated abnormalities in adap-
tive immunity against specific antigens in COPD patients
[26], and rekindled interest in the role of autoimmunity as
a central mechanism in the pathogenesis of COPD [2].
Relatively little is know about the roles of dendritic cells
in the pathogenesis of cigarette smoke-induced COPD. In
the current study we utilized human COPD tissue speci-
mens and other experimental models to provide evidence
consistent with recently published studies reporting
increased dendritic cell numbers in COPD [3]. We
expand the observations reported in that study by show-
ing that COPD is associated with a significant increase in
the total number of CD83+ dendritic cells. We demon-Vassallo et al. Respiratory Research 2010, 11:45
http://respiratory-research.com/content/11/1/45
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strate that COPD lung tissue contains increased levels of
the Langerhans cell restricted gene CD207, and that there
is correlation between osteopontin and CD207 gene lev-
els. The current study shows that CSE and cigarette
smoke enhance human and murine dendritic cell survival
respectively, and that CSE induces endogenous dendritic
cell pro-survival factors. This study also shows that
although activated dendritic cells conditioned with CSE
have diminished migratory CCR7 expression - an effect
induced by oxidative constituents in CSE - migration of
CSE-conditioned activated dendritic cells towards the
CCR7 ligand CCL21 is not impaired, implying that reten-
tion of activated dendritic cells due to impaired CCR7-
d e p e n d e n t  m i g r a t i o n  i s  u n l i k e l y  t o  b e  a n  i m p o r t a n t
mechanism for the increased dendritic cell numbers in
COPD.
Virtually all lung compartments (conducting airways,
interstitial and alveolar spaces, vascular structures, and
pleura) contain dendritic cells [4]. Whereas, in mice, the
integrin CD11c is a reasonable marker to identify murine
dendritic cells, human lung dendritic cells are more chal-
lenging to characterize [4,27]. The trachea and large con-
ducting airways have a well-developed network of
intraepithelial dendritic cells which share many proper-
ties with skin Langerhans' cells, and express intracellular
CD207 and surface CD1a [4]. Although some studies
have suggested that cigarette smoke exposure is associ-
ated with a reduction in murine lung conventional den-
dritic cell populations [28,29], the majority of studies
(including our own [30]) report expansion of murine lung
dendritic cell numbers following chronic (generally
defined as 4 weeks or greater) cigarette smoke exposure
Figure 4 Cigarette smoke extract inhibits CCR7 expression but does not suppress migration of dendritic cells towards a CCR7 ligand. A) Hu-
man dendritic cells were incubated for 18 hours in the presence or absence of 1% CSE. The NAC group was pretreated with 1 mM NAC for 60 minutes 
prior to the addition of 1% CSE and LPS. The nicotine group was pretreated with 1000 ng/ml nicotine for 60 minutes prior to the addition of LPS. Sur-
face CCR7 expression was subsequently determined with flow cytometry. The numbers in the quadrants refer to the percentage of cells in that quad-
rant. Data shown is representative of 3 independent experiments. B) Human dendritic cells (1 × 106/ml in 5 ml complete media) were incubated 
overnight with or without 2% CSE, or 1 mM NAC. Whole cellular CCR7 protein levels were determined following 18 hours using immunoblotting. β-
Actin protein levels were determined as an internal control to ensure equal protein loading. Data shown is representative of 3 independent experi-
ments. C) Half a million dendritic cells under different conditions suspended in 0.5 ml RPMI without serum, placed in cell culture inserts, and inserted 
into wells containing 0.5 ml of RPMI with 10% fetal calf serum and 10 ng/ml of CCL21. The number of migrated cells in the lower chamber was deter-
mined using flow cytometry. Data shown Data shown are means ± SEM. Data shown is representative of 4 independent experiments.
A.
C.
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[30-35]. Increased numbers of lung dendritic cells were
also reported to occur in SCID mice exposed to chronic
cigarette smoke exposure [36]. Cigarette smoke also
increases the number of lung dendritic cells following
allergen challenge in murine lungs [31]. The current
study provides additional evidence that COPD is associ-
ated with increased numbers of matured dendritic cells
identifiable by the marker CD83. Our data are consistent
with a recent report by Freeman et al, in which CD80 and
CD83 expression on isolated lung dendritic cells were
reported to increase with severity of COPD [37]. A limi-
tation of the current study is a lack of a non-smoking
group as a control, as all patients from whom lung tissue
was procured where either current or former smokers at
the time of lung biopsy. Nevertheless, the current study
shows that in smokers (either current or former) with
COPD, increased numbers of CD83+ cells and CD207
mRNA occurs, which cannot be explained simply by
chronic exposure to tobacco since the cumulative expo-
sure to tobacco in the two groups was not different.
Another limitation of our study is that is does not defini-
tively show that COPD is associated with increased num-
bers of either Langerhans type dendritic cells or matured
myeloid dendritic cells, as it may be argued that an alter-
native explanation to our findings is that COPD is associ-
ated with altered expression of these receptors or
d e n d r i t i c  c e l l  m a r k e r s ,  r a t h e r  t h a n  a n  i n c r e a s e  i n  t h e
respective dendritic cell populations per se.
It is well recognized that cigarette smoke modulates
immunity by altering the function of several immune
cells, including dendritic cells [11,25,30,33,38]. Cigarette
smoke constituents known to having immune altering
effects include nicotine [39-43], carbon monoxide [44],
acrolein [45], reactive oxidant species [46], peroxynitrites
[47], and possibly others. In the current study we did not
identify a specific cigarette smoke constituent responsi-
ble for altered dendritic cell viability or induction of pro-
survival cellular proteins. The current study implicates
reactive oxidative species [47,48], a term which broadly
refers to a wide collection of chemicals present in ciga-
rette smoke that have the capacity to increase cellular oxi-
dative stress. In addition to oxidative stress, other
cigarette smoke constituents may also be responsible for
altered dendritic cell viability and retention in COPD.
Although our data suggests that nicotine is not primarily
responsible for enhanced dendritic cell survival in vitro,
or augmentation of dendritic cell survival proteins, it
does not completely rule out the possibility that nicotine
may have additive or synergistic effects with other chemi-
cals in cigarette smoke (including those that induce cellu-
lar oxidative stress) that may have a significant effect on
dendritic cell survival and retention in the COPD lung.
Our findings differ with a recent report that showed a
reduction in CD83+ dendritic cells in COPD tissues com-
pared to controls [6]. In that study, mature dendritic cells
defined as CD83+ cells, were identified by immunohis-
tochemistry on 41 lung tissue samples from individuals
with COPD [6]. In contrast to the findings described in
the current report, those authors observed fewer num-
bers of CD83+ cells in the small airways of COPD tissue
compared with control smokers without COPD and non-
smoker controls [6]. The reasons for the discrepant find-
ings are not clear. In the study by Tsoumakidou et al [6],
all subjects had primary lung carcinoma. In the current
study, 20 out of the 24 subjects (5 of the 8 controls and 17
of the 18 COPD samples) used in the immunohistochem-
ical determination of CD83 had a diagnosis of either non-
small cell (15) or small cell carcinoma (5). Although can-
cer itself is known to be associated with reduced numbers
of mature dendritic cells, this is not likely to have been a
source of bias, since our study showed greater CD83
staining in COPD tissue (virtually all of which had coexis-
t e n t  l u n g  c a r c i n o m a )  c o m p a r e d  t o  c o n t r o l s .  A n o t h e r
potential source of bias in our study is the lack of infor-
mation regarding corticosteroid therapy in COPD
patients included in the current analysis. However, this is
highly unlikely to have significantly altered the conclu-
sions of the study, since corticosteroid therapy has been
associated with a reduction - rather than an increase - in
a number of dendritic cells functions, including matura-
tion [49-51].
The mechanisms by which smoking promotes dendritic
cell recruitment or retention in the lung are not fully elu-
cidated. The current study demonstrates that cigarette
smoke components activate endogenous dendritic cell
survival pathways. In this report, we focused on two key
intermediary molecules that have previously been
reported to have important roles in protecting cells from
death by apoptosis [19]. We used an in vitro approach
with CSE as a stimulant to determine whether cigarette
smoke induces pro-survival factors in dendritic cells.
This approach was utilized in favor of direct determina-
tion of protein levels in lung tissue dendritic cells. Den-
dritic cells are a rare population of cells, and quantitative
determination of cellular protein levels in human lung tis-
sue is extremely difficult to accomplish. Bcl-xL is a mem-
ber of the Bcl-2 family of apoptosis regulators that
control apoptotic cellular response to oxidants and other
stressors [20,21]. Heme-oxygenase-1 is a cellular stress
response protein shown to be induced by a variety of cel-
lular stressors including cigarette smoke [52-55]. Incuba-
tion of human dendritic cells with CSE resulted in
induction of HO-1 and Bcl-xL protein levels, and sug-
gests that induction of pro-survival factors by CSE may
be an important mechanism by which CSE promotes
dendritic cell survival in vitro. Our data do not provide
direct evidence that CSE-induced HO-1 or Bcl-xL pro-
mote dendritic cell survival. This proved impossible toVassallo et al. Respiratory Research 2010, 11:45
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test, as many of the techniques used to abrogate upregu-
lation of these proteins (including siRNA or pharmaco-
logic inhibitors), also resulted in diminished cellular
survival due to cell toxicity or other non-specific effects.
Abnormalities in chemokine expression may also be
responsible for excessive influx and delayed trafficking of
dendritic cells. Demedts and colleagues identified CCR6
expression on dendritic cells and elevated CCL20 levels
in sputum samples from COPD patients suggesting a
potential interaction between dendritic cell CCR6 and
epithelial CCL20 expression as a potential mechanism
explaining the enhanced Langerhans cell numbers seen in
COPD patients in their study [3]. Concordant with that
observation, Brattke and colleagues showed that myeloid
dendritic cells obtained by BAL from smokers expressed
lower levels of surface CCR7, a chemokine receptor
expressed by activated dendritic cells and required for
migration out of the lung and homing to lymph nodes
[25]. Those studies suggest the possibility that enhanced
dendritic cell retention occurs in COPD due to epithelial-
dendritic cell interactions and endogenous abnormalities
in dendritic cell chemokine receptor expression. Our
findings expand on those observations. We demonstrate
that relative osteopontin gene transcript levels correlate
highly with CD207 gene levels. Osteopontin is a secreted
phosphoprotein potently induced in epithelial cells by
CSE [13], that regulates a variety of dendritic cell func-
tions ranging from survival, maturation, and migration.
While our data does not prove any direct association
between induction of the osteopontin gene and dendritic
cell infiltration in COPD, it does indicate parallel induc-
tion of the osteopontin and CD207 genes occurs in smok-
ers with COPD, and suggests the possibility that cigarette
smoke-induced osteopontin levels in the lung may be
involved in recruitment or formation of Langerhans type
dendritic cells in smokers with COPD. In support of this
contention is a recent study that reported an increase in
pulmonary Langerhans cells and macrophages in murine
lungs that over-expressed osteopontin following delivery
of the human osteopontin gene by an adenoviral vector
[16]. In the current report we also sought to determine
whether the reduced CCR7 expression described to occur
in human dendritic cells isolated by BAL from smokers
[25], or observed in human dendritic cells conditioned by
CSE in vitro [11], is associated with reduced migration.
We initially hypothesized that CSE-conditioned dendritic
cells would have diminished migration towards a CCR7
ligand. The current report demonstrates that although
CSE suppresses CCR7 expression in vitro, there is no lim-
itation in dendritic cell migration towards CCR7 ligands.
Although contrary to our original hypothesis, this data is
consistent with the report by Robbins et al that found no
difference in the migration of ovalbumin-loaded lung
dendritic cells - achieved by intra-tracheal delivery of
FITC-tagged ovalbumin - to the regional lymph nodes in
mice chronically exposed to cigarette smoke [29]. In addi-
tion to migration, the CCR7 receptor is responsible for a
number of non-migratory dendritic cell functions that
may be relevant to COPD pathogenesis. Thus, it is con-
ceivable that although migration towards CCR7 ligands is
intact in dendritic cells conditioned by CSE, other CCR7-
dependent non-migratory dendritic cell functions in
smokers may be significantly altered.
In conclusion, we have used a number of complimen-
tary approaches using human COPD lung tissue, in vitro
and in vivo murine models to demonstrate that COPD is
associated with increased numbers of cells bearing the
CD83 receptor and CD207, and that CSE and cigarette
smoke enhance dendritic cell survival. Enhanced osteo-
pontin levels and augmented dendritic cell pro-survival
factors are potential mechanisms that mediate the
increased dendritic cell numbers. Our data do not sup-
port reduced emigration due to suppressed CCR7 expres-
sion as a mechanism for dendritic cell retention in the
lungs of smokers. Elucidating the roles of dendritic cells
in COPD will be essential in the quest for understanding
the pathogenesis and ultimately therapy of this frustrat-
ing disease.
Abbreviations used
FEV1: forced expiratory volume in 1 second; FVC: forced
vital capacity; COPD: chronic obstructive pulmonary dis-
ease; HO-1: heme-oxygenase-1; Bcl-xL: B cell lymphoma
leukemia-x(L); NAC: N acetyl cysteine; RPMI: Roswell
Park Memorial Institute media; LPS: lipopolysaccharide;
RIN: RNA integrity number; LTRC: lung tissue research
consortium
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RV obtained funding for experiments on murine and human dendritic cells,
conducted experiments, analyzed data, generated figures, and wrote the man-
uscript. PRW designed and performed the murine and human dendritic cell
experiments; collected and analyzed data. JL conducted all the experiments
using human COPD tissue. TJK performed the PCR experiments described. ESY
assisted with morphologic interpretation and immunohistochemical analysis.
AHL obtaining funding for immunohistochemical tissue analysis, provided
input on data analysis and interpretation, and helped prepare the final manu-
script. All authors read and approved the final manuscript.
Acknowledgements
Supported by a Flight Attendant Medical Research Institute grant, NIH grants 
HL96829Z-01, NHLBI NOI HR46161-05 and 1UL1 RR024150 from the National 
Center for Research Resources (NCRR).
Author Details
1The Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, 
Department of Internal Medicine, the Clinical Immunology and 
Immunotherapeutics Program, Mayo Clinic and Foundation, Rochester, 
Minnesota, 55905, USA, 2The Division of Anatomic Pathology, Mayo Clinic and 
Foundation, Rochester, Minnesota, 55905, USA and 3The Department of 
Biochemistry and Molecular Biology, Mayo Clinic and Foundation, Rochester, 
Minnesota, 55905, USAVassallo et al. Respiratory Research 2010, 11:45
http://respiratory-research.com/content/11/1/45
Page 12 of 13
References
1. Pauwels RA, Rabe KF: Burden and clinical features of chronic obstructive 
pulmonary disease (COPD).  Lancet 2004, 364(9434):613-620.
2. Cosio MG, Saetta M, Agusti A: Immunologic aspects of chronic 
obstructive pulmonary disease.  N Engl J Med 2009, 360(23):2445-2454.
3. Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, 
Vermassen FE, Joos GF, Brusselle GG: Accumulation of dendritic cells and 
increased CCL20 levels in the airways of patients with chronic 
obstructive pulmonary disease.  Am J Respir Crit Care Med 2007, 
175(10):998-1005.
4. Vermaelen K, Pauwels R: Pulmonary dendritic cells.  Am J Respir Crit Care 
Med 2005, 172(5):530-551.
5. Tsoumakidou M, Demedts IK, Brusselle GG, Jeffery PK: Dendritic cells in 
chronic obstructive pulmonary disease: new players in an old game.  
Am J Respir Crit Care Med 2008, 177(11):1180-1186.
6. Tsoumakidou M, Koutsopoulos AV, Tzanakis N, Dambaki K, Tzortzaki E, 
Zakynthinos S, Jeffery PK, Siafakas NM: Decreased Small Airway and 
Alveolar CD83+ Dendritic Cells in COPD.  Chest 2009.
7. Rogers AV, Adelroth E, Hattotuwa K, Dewar A, Jeffery PK: Bronchial 
mucosal dendritic cells in smokers and ex-smokers with COPD: an 
electron microscopic study.  Thorax 2008, 63(2):108-114.
8. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy 
for the diagnosis, management, and prevention of chronic obstructive 
pulmonary disease. NHLBI/WHO Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) Workshop summary.  Am J Respir Crit 
Care Med 2001, 163(5):1256-1276.
9. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, 
Jenkins C, Rodriguez-Roisin R, van Weel C, et al.: Global strategy for the 
diagnosis, management, and prevention of chronic obstructive 
pulmonary disease: GOLD executive summary.  Am J Respir Crit Care Med 
2007, 176(6):532-555.
10. Bongartz T, Cantaert T, Atkins SR, Harle P, Myers JL, Turesson C, Ryu JH, 
Baeten D, Matteson EL: Citrullination in extra-articular manifestations of 
rheumatoid arthritis.  Rheumatology (Oxford) 2007, 46(1):70-75.
11. Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L: Cigarette smoke 
extract suppresses human dendritic cell function leading to 
preferential induction of Th-2 priming.  J Immunol 2005, 
175(4):2684-2691.
12. Kroening PR, Barnes TW, Pease L, Limper A, Kita H, Vassallo R: Cigarette 
smoke-induced oxidative stress suppresses generation of dendritic cell 
IL-12 and IL-23 through ERK-dependent pathways.  J Immunol 2008, 
181(2):1536-1547.
13. Parsanejad R, Fields WR, Steichen TJ, Bombick BR, Doolittle DJ: Distinct 
regulatory profiles of interleukins and chemokines in response to 
cigarette smoke condensate in normal human bronchial epithelial 
(NHBE) cells.  J Interferon Cytokine Res 2008, 28(12):703-712.
14. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM, 
Paquet AC, Erle DJ: A distinctive alveolar macrophage activation state 
induced by cigarette smoking.  Am J Respir Crit Care Med 2005, 
172(11):1383-1392.
15. Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, 
Lambrecht BN, Lloyd CM, Panoutsakopoulou V: Osteopontin has a crucial 
role in allergic airway disease through regulation of dendritic cell 
subsets.  Nat Med 2007, 13(5):570-578.
16. Prasse A, Stahl M, Schulz G, Kayser G, Wang L, Ask K, Yalcintepe J, 
Kirschbaum A, Bargagli E, Zissel G, et al.: Essential role of osteopontin in 
smoking-related interstitial lung diseases.  Am J Pathol 2009, 
174(5):1683-1691.
17. Jarvik ME, Madsen DC, Olmstead RE, Iwamoto-Schaap PN, Elins JL, 
Benowitz NL: Nicotine blood levels and subjective craving for 
cigarettes.  Pharmacol Biochem Behav 2000, 66(3):553-558.
18. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED: 
Higher levels of nicotine in arterial than in venous blood after cigarette 
smoking.  Drug Alcohol Depend 1993, 33(1):23-29.
19. Tomita K, Caramori G, Lim S, Ito K, Hanazawa T, Oates T, Chiselita I, Jazrawi 
E, Chung KF, Barnes PJ, et al.: Increased p21(CIP1/WAF1) and B cell 
lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar 
macrophages from smokers.  Am J Respir Crit Care Med 2002, 
166(5):724-731.
20. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, 
Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that 
functions as a dominant regulator of apoptotic cell death.  Cell 1993, 
74(4):597-608.
21. Hon H, Rucker EB III, Hennighausen L, Jacob J: bcl-xL is critical for 
dendritic cell survival in vivo.  J Immunol 2004, 173(7):4425-4432.
22. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp 
M: CCR7 coordinates the primary immune response by establishing 
functional microenvironments in secondary lymphoid organs.  Cell 
1999, 99(1):23-33.
23. Jang MH, Sougawa N, Tanaka T, Hirata T, Hiroi T, Tohya K, Guo Z, Umemoto 
E, Ebisuno Y, Yang BG, et al.: CCR7 is critically important for migration of 
dendritic cells in intestinal lamina propria to mesenteric lymph nodes.  
J Immunol 2006, 176(2):803-810.
24. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, Blankenstein 
T, Henning G, Forster R: CCR7 governs skin dendritic cell migration 
under inflammatory and steady-state conditions.  Immunity 2004, 
21(2):279-288.
25. Bratke K, Klug M, Bier A, Julius P, Kuepper M, Virchow JC, Lommatzsch M: 
Function-associated surface molecules on airway dendritic cells in 
cigarette smokers.  Am J Respir Cell Mol Biol 2008, 38(6):655-660.
26. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green 
L, Hacken-Bitar J, Huh J, Bakaeen F, et al.: Antielastin autoimmunity in 
tobacco smoking-induced emphysema.  Nat Med 2007, 13(5):567-569.
27. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, Wu S, 
Vuthoori S, Ko K, Zavala F, et al.: In vivo depletion of CD11c(+) dendritic 
cells abrogates priming of CD8(+) T cells by exogenous cell-associated 
antigens.  Immunity 2002, 17(2):211-220.
28. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, 
Cox G, Stampfli MR: Cigarette smoke decreases pulmonary dendritic 
cells and impacts antiviral immune responsiveness.  Am J Respir Cell Mol 
Biol 2004, 30(2):202-211.
29. Robbins CS, Franco F, Mouded M, Cernadas M, Shapiro SD: Cigarette 
smoke exposure impairs dendritic cell maturation and T cell 
proliferation in thoracic lymph nodes of mice.  J Immunol 2008, 
180(10):6623-6628.
30. Vassallo R, Kroening PR, Parambil J, Kita H: Nicotine and oxidative 
cigarette smoke constituents induce immune-modulatory and pro-
inflammatory dendritic cell responses.  Mol Immunol 2008, 
45(12):3321-3329.
31. Van Hove CL, Moerloose K, Maes T, Joos GF, Tournoy KG: Cigarette smoke 
enhances Th-2 driven airway inflammation and delays inhalational 
tolerance.  Respir Res 2008, 9:42.
32. Bracke KR, D'Hulst AI, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos 
GF, Brusselle GG: Cigarette smoke-induced pulmonary inflammation 
and emphysema are attenuated in CCR6-deficient mice.  J Immunol 
2006, 177(7):4350-4359.
33. D'Hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA: Time course 
of cigarette smoke-induced pulmonary inflammation in mice.  Eur 
Respir J 2005, 26(2):204-213.
34. Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA, 
Brusselle GG: Murine TLR4 is implicated in cigarette smoke-induced 
pulmonary inflammation.  Int Arch Allergy Immunol 2006, 141(4):354-368.
35. Botelho FM, Gaschler GJ, Kianpour S, Zavitz CC, Trimble NJ, Nikota JK, 
Bauer CM, Stampfli MR: Innate Immune Processes are Sufficient for 
Driving Cigarette Smoke Induced Inflammation in Mice.  Am J Respir Cell 
Mol Biol 2009, 42(4):394-403.
36. D'Hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, Brusselle 
GG: Cigarette smoke-induced pulmonary emphysema in scid-mice. Is 
the acquired immune system required?  Respir Res 2005, 6:147.
37. Freeman CM, Martinez FJ, Han MK, Ames TM, Chensue SW, Todt JC, 
Arenberg DA, Meldrum CA, Getty C, McCloskey L, et al.: Lung Dendritic 
Cell Expression of Maturation Molecules Increases with Worsening 
COPD.  Am J Respir Crit Care Med 2009, 180(12):1179-88.
38. Lu LM, Zavitz CC, Chen B, Kianpour S, Wan Y, Stampfli MR: Cigarette 
smoke impairs NK cell-dependent tumor immune surveillance.  J 
Immunol 2007, 178(2):936-943.
39. Aicher A, Heeschen C, Mohaupt M, Cooke JP, Zeiher AM, Dimmeler S: 
Nicotine strongly activates dendritic cell-mediated adaptive immunity: 
Received: 22 October 2009 Accepted: 26 April 2010 
Published: 26 April 2010
This article is available from: http://respiratory-research.com/content/11/1/45 © 2010 Vassallo et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Respiratory Research 2010, 11:45Vassallo et al. Respiratory Research 2010, 11:45
http://respiratory-research.com/content/11/1/45
Page 13 of 13
potential role for progression of atherosclerotic lesions.  Circulation 
2003, 107(4):604-611.
40. Mamata Y, Hakki A, Yamamoto Y, Newton C, Klein TW, Pross S, Friedman H: 
Nicotine modulates cytokine production by Chlamydia pneumoniae 
infected human peripheral blood cells.  Int Immunopharmacol 2005, 
5(4):749-756.
41. Matsunaga K, Klein TW, Friedman H, Yamamoto Y: Involvement of 
nicotinic acetylcholine receptors in suppression of antimicrobial 
activity and cytokine responses of alveolar macrophages to Legionella 
pneumophila infection by nicotine.  J Immunol 2001, 
167(11):6518-6524.
42. Nouri-Shirazi M, Guinet E: Evidence for the immunosuppressive role of 
nicotine on human dendritic cell functions.  Immunology 2003, 
109(3):365-373.
43. Zhang S, Petro TM: The effect of nicotine on murine CD4 T cell 
responses.  Int J Immunopharmacol 1996, 18(8-9):467-478.
44. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE: Carbon 
monoxide ameliorates chronic murine colitis through a heme 
oxygenase 1-dependent pathway.  J Exp Med 2005, 202(12):1703-1713.
45. Lambert C, McCue J, Portas M, Ouyang Y, Li J, Rosano TG, Lazis A, Freed 
BM: Acrolein in cigarette smoke inhibits T-cell responses.  J Allergy Clin 
Immunol 2005, 116(4):916-922.
46. Khan N, Rahim SS, Boddupalli CS, Ghousunnissa S, Padma S, Pathak N, 
Thiagarajan D, Hasnain SE, Mukhopadhyay S: Hydrogen peroxide inhibits 
IL-12 p40 induction in macrophages by inhibiting c-rel translocation to 
the nucleus through activation of calmodulin protein.  Blood 2006, 
107(4):1513-1520.
47. Muller T, Haussmann HJ, Schepers G: Evidence for peroxynitrite as an 
oxidative stress-inducing compound of aqueous cigarette smoke 
fractions.  Carcinogenesis 1997, 18(2):295-301.
48. Pryor WA: Cigarette smoke radicals and the role of free radicals in 
chemical carcinogenicity.  Environ Health Perspect 1997, 105(Suppl 
4):875-882.
49. Moller GM, Overbeek SE, Van Helden-Meeuwsen CG, Van Haarst JM, Prens 
EP, Mulder PG, Postma DS, Hoogsteden HC: Increased numbers of 
dendritic cells in the bronchial mucosa of atopic asthmatic patients: 
downregulation by inhaled corticosteroids.  Clin Exp Allergy 1996, 
26(5):517-524.
50. Georas SN: Inhaled glucocorticoids, lymphocytes, and dendritic cells in 
asthma and obstructive lung diseases.  Proc Am Thorac Soc 2004, 
1(3):215-221.
51. Verhoeven GT, Van Haarst JM, De Wit HJ, Simons PJ, Hoogsteden HC, 
Drexhage HA: Glucocorticoids hamper the ex vivo maturation of lung 
dendritic cells from their low autofluorescent precursors in the human 
bronchoalveolar lavage: decreases in allostimulatory capacity and 
expression of CD80 and CD86.  Clin Exp Immunol 2000, 122(2):232-240.
52. Sexton K, Balharry D, BeruBe KA: Genomic biomarkers of pulmonary 
exposure to tobacco smoke components.  Pharmacogenet Genomics 
2008, 18(10):853-860.
53. Almolki A, Guenegou A, Golda S, Boyer L, Benallaoua M, Amara N, 
Bachoual R, Martin C, Rannou F, Lanone S, et al.: Heme oxygenase-1 
prevents airway mucus hypersecretion induced by cigarette smoke in 
rodents and humans.  Am J Pathol 2008, 173(4):981-992.
54. Kim HP, Wang X, Chen ZH, Lee SJ, Huang MH, Wang Y, Ryter SW, Choi AM: 
Autophagic proteins regulate cigarette smoke-induced apoptosis: 
protective role of heme oxygenase-1.  Autophagy 2008, 4(7):887-895.
55. Baglole CJ, Sime PJ, Phipps RP: Cigarette smoke-induced expression of 
heme oxygenase-1 in human lung fibroblasts is regulated by 
intracellular glutathione.  Am J Physiol Lung Cell Mol Physiol 2008, 
295(4):L624-636.
doi: 10.1186/1465-9921-11-45
Cite this article as: Vassallo et al., Cigarette smoke promotes dendritic cell 
accumulation in COPD; a Lung Tissue Research Consortium study Respiratory 
Research 2010, 11:45